All filters
Slidesets
The initial Phase 1 evaluation of the safety, tolerability, and pharmacokinetics of GSK3640254 - Samit Joshi, MD
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Slidesets
Novel antiviral and immune targets to cure HBV - Fabien Zoulim, MD
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Slidesets
Improved long acting drug delivery: What are the technologies - Andrew Owen, BSc, MSc, PhD, FSB
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Slidesets
Long acting HIV drugs for treatment: Data and potential implementation - Charles Flexner, MD
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Slidesets
Long Acting HIV Drugs for Prevention: Data and Potential implementation - Laura Waters, MD
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Slidesets
Clinical Case Presentation - Catia Marzolini, PharmD, PhD
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Slidesets
Changes in drug interaction profiles for first-line HIV therapy over the 20 years of the Liverpool Drug Interaction website - Sara Gibbons
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Slidesets
Effect of CYP2b6 metabolizer status on levonorgestrel pharmacokinetics when combined with efavirenz-based antiretroviral therapy - Michelle Pham
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Slidesets
Drugs abuse and chemsex a new challenge for antiretroviral drug-drug interaction - Tess Martin
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Slidesets
Dual Maintenance for HIV: Con Perspective - Andrew Hill, MD
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Slidesets
Dual Maintenance for HIV: Pro Perspective - José Ramón Arribas, MD
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Videos
CRISPR/Cas and Gene Editing for HIV - Paula Cannon
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Videos
Dual Maintenance for HIV: Why Fix it if it's not Broken? (Debate: Discussion)
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Videos
Dual Maintenance for HIV: Why Fix it if it's not Broken? (Debate: Pro) - Jose Arribas
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Videos
Dual Maintenance for HIV: Why Fix it if it's not Broken? (Debate: Con) - Andrew Hill
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Videos
Clinical Case Presentation - Catia Marzolini
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Videos
Long-Acting HIV Drugs for Treatment: Data and Potential Implementation - Laura Waters
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Videos
Long-Acting HIV Drugs for Treatment: Data and Potential Implementation - Charles Flexner
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Videos
Improved Long-Acting Drug Delivery: What are the Technologies? - Andrew Owen
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Videos
Pharmacological Treatment of NASH - Sven Francque
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Videos
Novel Antiviral and Immune Targets to Cure HBV - Fabien Zoulim
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Videos
The "Third Wave" of TB Drug Development: What's on the Horizon - Kelly Dooley
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Videos
50% Adherence is Enough with Modern ARVs, Right? - Terrence Blaschke
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Videos
End of Conference Discussion led by Manal El-Sayed
Presented at:
Conference on Liver Disease in Africa (COLDA) 2019